VIVO Cannabis’ (VVCIF) Buy Rating Reiterated at Clarus Securities

Clarus Securities reaffirmed their buy rating on shares of VIVO Cannabis (OTCMKTS:VVCIF) in a research report released on Tuesday, AnalystRatings.com reports. Clarus Securities currently has a $0.70 price objective on the stock.

Separately, Canaccord Genuity downgraded VIVO Cannabis from a buy rating to a hold rating in a report on Wednesday, November 20th.

OTCMKTS:VVCIF opened at $0.30 on Tuesday. VIVO Cannabis has a 52-week low of $0.14 and a 52-week high of $0.93. The stock has a 50-day simple moving average of $0.17 and a 200 day simple moving average of $0.26.

About VIVO Cannabis

VIVO Cannabis Inc manufactures and distributes medical cannabis. The company was formerly known as ABcann Global Corporation and changed its name to VIVO Cannabis Inc in August 2018. The company is headquartered in Napanee, Canada.

Recommended Story: Compound Annual Growth Rate (CAGR)

Receive News & Ratings for VIVO Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VIVO Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.